Merck KGaA, Darmstadt, Germany[Grants and Funding] - Search Results

Year	Number of Results
2020	3
2021	11
2022	4
2023	10
2024	20

1

Long-term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study.

Morise M, Kato T, Matsumoto S, Inoue T, Sakamoto T, Tokito T, Atagi S, Kozuki T, Takeoka H, Chikamori K, Shinagawa N, Tanaka H, Horii E, Adrian S, Bruns R, Johne A, Paik PK, Sakai H. Morise M, et al. Cancer Sci. 2024 Apr;115(4):1296-1305. doi: 10.1111/cas.16107. Epub 2024 Feb 25. Cancer Sci. 2024. PMID: 38402853 Free PMC article. Clinical Trial.

2

First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors.

Yap TA, Tolcher AW, Plummer R, Mukker JK, Enderlin M, Hicking C, Grombacher T, Locatelli G, Szucs Z, Gounaris I, de Bono JS. Yap TA, et al. Clin Cancer Res. 2024 May 15;30(10):2057-2067. doi: 10.1158/1078-0432.CCR-23-2409. Clin Cancer Res. 2024. PMID: 38407317 Free PMC article. Clinical Trial.

3

Programming a Ferroptosis-to-Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy.

Vinik Y, Maimon A, Dubey V, Raj H, Abramovitch I, Malitsky S, Itkin M, Ma'ayan A, Westermann F, Gottlieb E, Ruppin E, Lev S. Vinik Y, et al. Adv Sci (Weinh). 2024 May;11(17):e2307263. doi: 10.1002/advs.202307263. Epub 2024 Mar 5. Adv Sci (Weinh). 2024. PMID: 38441406 Free PMC article.

4

Immunomodulatory Effects Associated with Cladribine Treatment.

Fissolo N, Calvo-Barreiro L, Eixarch H, Boschert U, Espejo C, Montalban X, Comabella M. Fissolo N, et al. Cells. 2021 Dec 10;10(12):3488. doi: 10.3390/cells10123488. Cells. 2021. PMID: 34943995 Free PMC article.

5

Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues.

Eslami M, Schuepbach-Mallepell S, Diana D, Willen L, Kowalczyk-Quintas C, Desponds C, Peter B, Vigolo M, Renevey F, Donzé O, Luther SA, Yalkinoglu Ö, Alouche N, Schneider P. Eslami M, et al. Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2404309121. doi: 10.1073/pnas.2404309121. Epub 2024 Jul 11. Proc Natl Acad Sci U S A. 2024. PMID: 38990948

6

Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer.

Oaknin A, Ghamande SA, Kasamatsu Y, Gil-Martin M, Grau-Bejar JF, Garcia-Duran C, Sato M, Siddiqui A, Chaudhary SP, Vugmeyster Y, Hasegawa K. Oaknin A, et al. Clin Cancer Res. 2024 Mar 1;30(5):975-983. doi: 10.1158/1078-0432.CCR-23-1829. Clin Cancer Res. 2024. PMID: 38165683 Free PMC article. Clinical Trial.

7

Cetuximab every 2 weeks versus standard weekly dosing administration schedule.

Bokemeyer C, Ciardiello F, Dubreuil O, Guigay J, Kasper S, Pfeiffer P, Pinto C, Yamaguchi K, Yoshino T, Zielinski C, Esser R, Tabernero J. Bokemeyer C, et al. Future Oncol. 2024 Mar;20(7):393-407. doi: 10.2217/fon-2023-0282. Epub 2023 Oct 18. Future Oncol. 2024. PMID: 37850363 Review.

8

Diagnostic and economic value of biomarker testing for targetable mutations in non-small-cell lung cancer: a literature review.

Zheng Y, Vioix H, Liu FX, Singh B, Sharma S, Sharda D. Zheng Y, et al. Future Oncol. 2022 Feb;18(4):505-518. doi: 10.2217/fon-2021-1040. Epub 2021 Dec 6. Future Oncol. 2022. PMID: 34865516 Review.

9

Gonadotropin Activity during Early Folliculogenesis and Implications for Polycystic Ovarian Syndrome and Premature Ovarian Insufficiency: A Narrative Review.

Longobardi S, Klinger FG, Zheng W, Campitiello MR, D'Hooghe T, La Marca A. Longobardi S, et al. Int J Mol Sci. 2024 Jul 9;25(14):7520. doi: 10.3390/ijms25147520. Int J Mol Sci. 2024. PMID: 39062762 Free PMC article. Review.

10

Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8.

Port A, Shaw JV, Klopp-Schulze L, Bytyqi A, Vetter C, Hussey E, Mammasse N, Ona V, Bachmann A, Strugala D, Reh C, Goteti K. Port A, et al. Pharmacol Res Perspect. 2021 Oct;9(5):e00842. doi: 10.1002/prp2.842. Pharmacol Res Perspect. 2021. PMID: 34414672 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Results by year